Answers are grounded in this paper and cite their sources.
Relative dose intensity (RDI) of chemotherapy in patients with aggressive lymphoma is related to survival outcomes [1]. The development of granulocyte colony-stimulating factor (G-CSF) has allowed ...
No takes yet. Share an insight, caveat, or question.
Johnsen et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: